Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for DH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 144.65M
March 31, 2026 146.23M
December 31, 2025 281.11M
September 30, 2025 284.85M
June 30, 2025 303.62M
March 31, 2025 322.78M
December 31, 2024 444.38M
September 30, 2024 506.52M
June 30, 2024 644.79M
March 31, 2024 860.29M
December 31, 2023 861.36M
September 30, 2023 863.28M
June 30, 2023 1.008B
March 31, 2023 984.47M
December 31, 2022 948.92M
Date Value
September 30, 2022 932.75M
June 30, 2022 900.48M
March 31, 2022 874.20M
December 31, 2021 871.31M
September 30, 2021 692.91M
June 30, 2021 1.174B
March 31, 2021 0.00
December 31, 2020 1.196B
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 1.216B
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. 7.053M
SCWorx Corp. 6.932M
Health Catalyst, Inc. 100.83M
GoodRx Holdings, Inc. 647.60M
Claritev Corp. -294.56M

Shareholders Equity (Quarterly) Related Metrics